Clinical efficacy of azacitidine in the treatment of middle- and high-risk myelodysplastic syndrome in middle-aged and elderly patients: A retrospective study
AZA is safe and effective in the treatment of high risk MDS in middle and old age patients.
Authors
- Bian Jian-jun
- Chunchun Zhang (ORCID: https://orcid.org/0000-0001-8558-6060)
- Yuxuan Su
- Liang Li
Institutions
- The Second Affiliated Hospital of Bengbu Medical College (CN)
Publication Details
- Journal
- Open Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1515/med-2025-1151
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00